SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-023267
Filing Date
2017-11-09
Accepted
2017-11-09 16:25:16
Documents
67
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-10q_20170930.htm 10-Q 1206512
2 EX-10.1 WHITE EMPLOYMENT AGREEMENT clsd-ex101_70.htm EX-10.1 81630
3 EX-10.2 DEIGNAN EMPLOYMENT AGREEMENT clsd-ex102_69.htm EX-10.2 80209
4 EX-10.3 NORONHA EMPLOYMENT AGREEMENT clsd-ex103_68.htm EX-10.3 79697
5 EX-10.4 DIRECTOR COMPENSATION POLICY clsd-ex104_281.htm EX-10.4 14478
6 EX-31.1 clsd-ex311_7.htm EX-31.1 15287
7 EX-31.2 clsd-ex312_6.htm EX-31.2 15282
8 EX-32.1 clsd-ex321_8.htm EX-32.1 9016
  Complete submission text file 0001564590-17-023267.txt   5171477

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT clsd-20170930.xml EX-101.INS 1087800
10 XBRL TAXONOMY EXTENSION SCHEMA clsd-20170930.xsd EX-101.SCH 44473
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsd-20170930_cal.xml EX-101.CAL 48438
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsd-20170930_def.xml EX-101.DEF 106329
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20170930_lab.xml EX-101.LAB 312933
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20170930_pre.xml EX-101.PRE 226556
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 171191205
SIC: 2834 Pharmaceutical Preparations